Pfizer sees blockbuster potential for lung cancer drug Lorbrena after strong new data from phase 3 trial ...Middle East

Pharma giant Pfizer said that its lung cancer drug Lorbrena could reach blockbuster status by 2030 after new data showed the drug helped patients survive five years without their cancer getting worse.Read more...

Hence then, the article about pfizer sees blockbuster potential for lung cancer drug lorbrena after strong new data from phase 3 trial was published today ( Friday 31/05/2024 - 05:52 PM ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pfizer sees blockbuster potential for lung cancer drug Lorbrena after strong new data from phase 3 trial )

Also on site :

• US Trade Dominance Will Soon Begin to Crack
• Apirone Unveils Updated Dashboard Built with Comprehensive Design System
• Uxin Announces Entry into Share Subscription Agreements with NIO Capital and Prestige Shine Group Limited